Pharmacy Focus

In this episode of Psychiatric Pharmacy Pulse , host Megan Maroney, PharmD, BCPP, FAAPP, talks with Mary Bridgeman, PharmD, a pharmacist and clinical professor at the Ernest Mario School of Pharmacy at Rutgers, about the federal effort to move cannabis from Schedule I to Schedule III of the Controlled Substances Act. Bridgeman explains that the federal order covers FDA-approved cannabis products a...

In this episode of Mind the Meds , host Erica Marini, PharmD, opens with the month's neurology pharmacy news: Novartis and Bristol Myers Squibb paused CAR T-cell trials in autoimmune diseases, including myasthenia gravis and multiple sclerosis, after safety concerns. FDA approvals included tavapadon (Juvmo; AbbVie), a selective D1/D5 dopamine agonist for Parkinson disease; apitegromab (Isembyld; S...

Cindy Valencia, PhD, MPH, is director of CA Quits at UC Davis Health Center for Healthcare Policy and Research. They can be found on LinkedIn . Robin Corelli, PharmD, is a professor of clinical pharmacy in the Department of Clinical Pharmacy at the School of Pharmacy of the University of California, San Francisco. You can read their bio here .

In this episode of Psychiatric Pharmacy Pulse, host Megan Maroney, PharmD, BCPP, FAAPP , speaks with Danielle Stutzman, PharmD, BCPP , clinical assistant professor at the University of Colorado Skaggs School of Pharmacy and assistant adjunct professor at the Child and Adolescent Mental Health Division of the Department of Psychiatry at the University of Colorado School of Medicine, and member of t...

This episode of Mind the Meds features guest Patti Yager-Stone, PharmD, BCPS, a clinical pharmacist in neurology at the Veterans Affairs Medical Center in Portland, Oregon, who oversees infusion management and vaccine coordination for about 120 neurology patients.  Yager-Stone explains that immunomodulating and immunosuppressant therapies both increase infection risk and can blunt vaccine response...

Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.

Megan Maroney, PharmD, BCPP, FAAPP: Hello, I'm Megan Maroney, and this is Psychiatric Pharmacy Pulse , a monthly podcast where we talk about hot topics in psychiatric pharmacy. I'm a clinical associate professor at the Ernest Mario School of Pharmacy at Rutgers University, and a clinical psychiatric pharmacist at Monmouth Medical Center. I am also a board-certified psychiatric pharmacist and a fel...

Matthew Lei, PharmD, BCOP, a clinical oncology pharmacist at Massachusetts General Hospital, joins Pharmacy Focus: Oncology Edition to break down the FDA approval of subcutaneous isatuximab-irfc via the CirCLIQ on-body injector, covering the IRAKLIA trial's noninferiority data, the device's practical rollout challenges, and how the agent positions against subcutaneous daratumumab in an increasingl...

In this episode of Mind the Meds , host Erica Marini, PharmD, MS, BCPS, welcomes Jenelle Hall Montgomery, PharmD, BCACP, CPP, a clinical pharmacist practitioner with Duke Neurological Disorders Clinic at Duke University Hospital, to discuss highlights from the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in Charlotte, North Carolina, where Montgomery was recognized as a Giant of...

Holistic, integrative, functional, precision—the labels are everywhere, but few patients or clinicians know where one ends and the next begins.

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for Huntington disease, and a similar back-and-forth for a Hunter syndrome gene therapy. She also noted an expanded indication for olezarsen (Tryngolza; Ionis Pharmaceuticals) in severe hypertriglyceride...

Updated ASTCT infectious disease guidelines are reshaping how BMT and cellular therapy pharmacists approach prophylaxis, treatment thresholds, and drug–drug interactions across a range of opportunistic infections.

Find out more information about the Psychedelic Pharmacists Foundation (PPF) & Psychedelic Pharmacists Association (PPA): PPF: https://www.psychedelicpharmacistsfoundation.org/ PPA: https://psychedelicpharmacist.org/

The discussion examines the evidence behind common concerns about everyday products, food trends, and lifestyle habits, while emphasizing a practical, individualized approach to health and cancer prevention.

A panel of clinical pharmacists meets to discuss the complex process of operationalizing cell and gene therapy at an academic medical center.

In this episode of Mind the Meds , Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian (Bayer), a factor XIa inhibitor showing reduced recurrent ischemic stroke risk without increased bleeding, as well as positive results from three trials of tirofiban in acute ischemic stroke settings. On the multiple sclerosis (MS)...

In this episode of Pharmacy Focus , moderator Bob Haight, PharmD, BCPP, AAPP Annual Meeting director and past president of American Association of Psychiatric Pharmacists (AAPP), discusses the AAPP 2026 Annual Meeting with Archana Jhawar, PharmD, BCPP, clinical assistant professor at the University of Illinois Chicago; and Chelsea Di Polito, PharmD, BCPP, psychiatric clinical pharmacist at the Uni...

You can connect with Marilyn Bulloch on LinkedIn here . Read more insights about hepatitis B throughout Hepatitis Awareness Month at Pharmacy Times' Hepatitis Resource Center . Episode Timestamps: 1:05: Introduction 2:08: Current Disease Burden of Hepatitis B 3:55: Risk Landscape for Adults 7:20: Link Between Chronic Hepatitis B and Liver Cancer 10:25: Expanded Vaccine Recommendations 13:25: The R...

When a cancer patient says "I've been doing some research," the conversation that follows can be just as complex as the treatment itself. In this episode, a malignant hematology clinical pharmacy specialist joins us to unpack health misinformation, AI-generated medical advice, wellness culture, and the controversial therapies oncology patients are bringing into the clinic — and how pharmacists can...

This inaugural episode of Mind the Meds introduces neurology pharmacy practice through a discussion between 3 neurology pharmacists working across inpatient and outpatient settings at the University of Utah. Host Erica Marini, PharmD , meets with her colleagues, Sarah Dahoney, PharmD , and Tyler Kenny, PharmD, BCCCP , both of whom are clinical pharmacists at the University of Utah Health, to discu...

Dr. JAM can be found on LinkedIn . Stay tuned for Pharmacy Times' coverage of APhA 2026 in LA. It can all be found here .